FOXO3 and neuroblastoma: In parallel, presumably due to selective pressure, also the number of FOXO3-negative tumor cells increased during therapy, suggesting increased heterogeneity of the residual tumor tissue after 4OHT-treatment, similar to stage IV NB tumors.